Correlation Between Eliem Therapeutics and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Transcode Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Transcode Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Transcode Therapeutics
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eliem and Transcode is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Transcode Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.81 times more return on investment than Transcode Therapeutics. However, Eliem Therapeutics is 1.24 times less risky than Transcode Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.28 per unit of risk. If you would invest 351.00 in Eliem Therapeutics on September 3, 2024 and sell it today you would lose (47.00) from holding Eliem Therapeutics or give up 13.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eliem Therapeutics vs. Transcode Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Transcode Therapeutics |
Eliem Therapeutics and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Transcode Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |